Announcements Trials
Browse Landscape

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Breast Neoplasms 3Sexuality 1Sexual Dysfunction, Physiological 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Infertility 1Hodgkin Disease 1Gastrointestinal Stromal Tumors 1Congenital Abnormalities 1

Interventions

Cytarabine 25Azacitidine 17fludarabine phosphate 15fludarabine 15Cyclophosphamide 14venetoclax 8Peripheral Blood Stem Cell Transplantation 8Methotrexate 8Busulfan 8Granulocyte Colony-Stimulating Factor 7Filgrastim 7Whole-Body Irradiation 6Decitabine 6Cyclosporine 6Injections 5Idarubicin 5decitabine and cedazuridine drug combination 4Tacrolimus 4Radiotherapy 4Mycophenolic Acid 4Mitoxantrone 4Daunorubicin 4Cladribine 4CPX-351 4Biopsy 4midostaurin 3merphos 3magrolimab 3gilteritinib 3Stem Cell Transplantation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Acute × High-Energy Shock Waves × Clear all
NCT00402935 2012-03-20

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Case Comprehensive Cancer Center

Withdrawn
LymphoidOtherOther hematologic neoplasm

Congenital Abnormalities, Hodgkin Disease, Infertility, Leukemia, Lymphoma, Recurrence, Sexual Dysfunction, Physiological, Leukemia, Myeloid, Acute, Sexuality, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡